Pulse Biosciences (NASDAQ:PLSE - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.25) earnings per share (EPS) for the quarter, Zacks reports.
Pulse Biosciences Stock Performance
PLSE stock traded up $0.26 during midday trading on Friday, hitting $17.11. The company's stock had a trading volume of 160,321 shares, compared to its average volume of 198,255. The firm has a 50-day simple moving average of $16.63 and a 200-day simple moving average of $18.01. Pulse Biosciences has a 52-week low of $6.66 and a 52-week high of $25.00.
Analyst Ratings Changes
Separately, StockNews.com upgraded shares of Pulse Biosciences to a "sell" rating in a research note on Monday, March 31st.
View Our Latest Analysis on Pulse Biosciences
Pulse Biosciences Company Profile
(
Get Free Report)
Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Pulse Biosciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pulse Biosciences wasn't on the list.
While Pulse Biosciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
